SUBSCRIBE
SUBSCRIBE
News   Deals

Genentech, Inc. (JOBS) CEO Sells 90,000 Shares Prior to Roche (JOBS) Bid

July 23, 2008 | 
1 min read
NEW YORK (Reuters) - If there was any doubt that Genentech Inc was caught by surprise by Roche's move to acquire the remaining stake in the biotechnology giant it doesn't already own, one need only look at recent executive stock transactions.
Mergers & acquisitions
Genentech, Inc. Roche
MORE ON THIS TOPIC
Big fish eats small, takeover of the company. Art collage.
Mergers & acquisitions
Neurocrine Nabs Rare Obesity Disorder Drug in ‘Surprising’ $2.9B Soleno Deal
April 6, 2026
 · 
2 min read
 · 
Tristan Manalac
Close-up Of Businessperson Shaking Hands With Robot
Mergers & acquisitions
AI Giant Anthropic Leans Into Life Sciences With $400M Coefficient Bio Catch
April 6, 2026
 · 
2 min read
 · 
Tristan Manalac
Two hands locked in a handshake cut by a pair of scissors, symbolizing a severed relationship or partnership. Black and white collage illustration on paper textured background
Neurodegenerative diseases
Takeda Breaks Up With Denali, Dumps Dementia Drug
April 6, 2026
 · 
2 min read
 · 
Tristan Manalac
Cartoon high-speed train in the white background, 3d rendering. Digital drawing.
Mergers & acquisitions
Pharma’s M&A Train Is on Track for Record Highs With More Deals To Come: Analysts
April 3, 2026
 · 
3 min read
 · 
Annalee Armstrong